GENERAL FLUIDICS CORPORATION

General Fluidics Corporation, based in Waltham, Massachusetts, is an in-vitro diagnostics company founded in 2013. The company specializes in advanced blood testing technology that brings comprehensive test menus directly to the point of care. Their flagship product, the Axess™ diagnostic platform, integrates multiple analytical technologies to deliver a wide range of hematology, clinical chemistry, and immunoassay tests. The Axess™ platform is a modular in-vitro diagnostic system designed for efficiency and flexibility. It streamlines the testing workflow from sample collection to result delivery, reducing the burden on clinical staff and minimizing errors. This platform supports various test panels through a single programmable cartridge, making high-quality diagnostics accessible in diverse healthcare settings. General Fluidics aims to enhance global health by providing faster, more flexible blood diagnostics. Their solutions cater to patients, healthcare providers, and payors, focusing on improving clinical outcomes and patient management through accessible and high-quality testing.

• Employees 15
• Founded 2014